AstraZeneca

India to withdraw AstraZeneca's cancer drug

by

The Drug Controller General of India (DCGI) has asked all state drug regulators to withdraw AstraZeneca‘s anti-cancer drug Olaparib tablets. This drug which is mostly used for the treatment of patients with gBRCA mutation and advanced ovarian cancer and breast cancer has potential adverse effects, DCGI has said.Olaparib tablets are a type of medication known … Read more

Woman claims permanently disability due to AstraZeneca's vaccine

by

Amidst growing concerns around the safety of COVID vaccines developed by AstraZeneca, a new claim has come to the fore. A 42 year old American woman has claimed that she was “permanently disabled” after taking AstraZeneca‘s COVID vaccine during the clinical trial process. She also claims that her disability was due to the failure by … Read more

MostBet